← Back to Clinical Trials
Recruiting NCT06901167

NCT06901167 Evaluation of a Residential In-Reach Program in Regional and Rural Australia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06901167
Status Recruiting
Phase
Sponsor Monash University
Condition Aged
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-05-01
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
Residential In-Reach Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-05-01 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Residential In-Reach (RIR) programs are designed to provide responsive care for residents in residential aged care homes (RACH) with the aim of avoiding unnecessary hospital transfers. The evidence for their clinical and cost-effectiveness and implementation has been established in urban settings, but there is a small amount of low-quality evidence for rural and regional settings. The Grampians Region Health Service Partnership Resi-In-Reach Redesign Committee will be implementing a new RIR program to be offered to all RACHs in the Grampians region, this project aims to evaluate the clinical and cost-effectiveness of this program, and its implementation in the rural and regional setting. A stepped-wedge trial will be conducted so that as the RIR program is gradually rolled-out across the region, outcomes can be compared in the same facilities across time and between different facilities. The primary outcome measure will be presentation to emergency departments and urgent care centres, and data will also be collected on other clinical outcomes and barriers and enablers of implementing the program. It is anticipated that there will be a reduction in hospital presentations, and a range of barriers and enablers unique to the rural and regional setting will emerge.

Eligibility Criteria

Inclusion Criteria: * Health services that have emergency departments and/or emergency care centres that admit residents from residential aged care homes (RACH) * RACHs that do not currently have access to RIR programs * health service staff who have been involved with the set-up and delivery of the RIR program, * RACH staff who have experience of or accessing the RIR service for residents at least once, * residents living at a RACH who has experienced receiving medical care from the RIR program and can provide informed consent, or a family member of the resident, * general practitioners whose case load includes residents from RACHs. Exclusion Criteria: • RACHs that already have access to a RIR program will be excluded

Contact & Investigator

Central Contact

Dai Pu

✉ debbie.pu@monash.edu

📞 61 03 9904 4004

Principal Investigator

Terry Haines

PRINCIPAL INVESTIGATOR

Monash University

Frequently Asked Questions

Who can join the NCT06901167 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Aged. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06901167 currently recruiting?

Yes, NCT06901167 is actively recruiting participants. Contact the research team at debbie.pu@monash.edu for enrollment information.

Where is the NCT06901167 trial being conducted?

This trial is being conducted at Ararat, Australia, Ballarat, Australia, Beaufort, Australia, Daylesford, Australia and 4 additional locations.

Who is sponsoring the NCT06901167 clinical trial?

NCT06901167 is sponsored by Monash University. The principal investigator is Terry Haines at Monash University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology